SF552 • 2026

A bill for an act relating to a review of anti-obesity medications by the department of health and human services and the department of administrative services for purposes of the medical assistance program and health insurance plans for state employees.(Formerly SSB 1138 .)

Healthcare Labor

Passed Legislature

This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.

Sponsor: COMMITTEE ON HEALTH AND HUMAN SERVICES
Last action: 2025-06-16
Official status: Referred to Health and Human Services. S.J. 1058 .
Effective date: Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

A bill for an act relating to a review of anti-obesity medications by the department of health and human services and the department of administrative services for purposes of the medical assistance program and health insurance plans for state employees.(Formerly SSB 1138 .)

What This Bill Does

A bill for an act relating to a review of anti-obesity medications by the department of health and human services and the department of administrative services for purposes of the medical assistance program and health insurance plans for state employees.(Formerly SSB 1138 .)

Limits and Unknowns

This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Bill History

2025-06-16 Iowa Legislature
Referred to Health and Human Services. S.J. 1058 .
2025-03-06 Iowa Legislature
Committee report, approving bill. S.J. 436 .
2025-03-06 Iowa Legislature
Introduced, placed on calendar. S.J. 431 .

Official Summary Text

A bill for an act relating to a review of anti-obesity medications by the department of health and human services and the department of administrative services for purposes of the medical assistance program and health insurance plans for state employees.(Formerly SSB 1138 .)

Current Bill Text

Read the full stored bill text

Senate

File

552

-

Introduced

SENATE

FILE

552

BY

COMMITTEE

ON

HEALTH

AND

HUMAN

SERVICES

(SUCCESSOR

TO

SSB

1138)

A

BILL

FOR

An

Act

relating

to

a

review

of

anti-obesity

medications

by

the

1

department

of

health

and

human

services

and

the

department

2

of

administrative

services

for

purposes

of

the

medical

3

assistance

program

and

health

insurance

plans

for

state

4

employees.

5

BE

IT

ENACTED

BY

THE

GENERAL

ASSEMBLY

OF

THE

STATE

OF

IOWA:

6

TLSB

1939SV

(2)

91

lh/ko

S.F.

552

Section

1.

ANTI-OBESITY

MEDICATION

REVIEW

AND

REPORT.

For

1

purposes

of

the

medical

assistance

program

under

chapter

249A

2

and

health

insurance

plans

for

state

employees

established

3

pursuant

to

chapter

509A,

the

department

of

health

and

human

4

services

and

the

department

of

administrative

services

shall

5

review

anti-obesity

medications,

including

GLP-1

agonists,

6

for

effectiveness

relating

to

weight

loss,

the

impact

7

on

comorbidities,

the

potential

for

cost

savings

due

to

8

deferred

medical

procedures

and

reduced

medications

related

9

to

comorbidity,

recommended

eligibility

requirements,

any

10

short-term

and

long-term

costs

associated

with

coverage,

11

and

any

other

criteria

the

departments

deem

relevant.

The

12

department

of

health

and

human

services

and

the

department

of

13

administrative

services

shall

submit

a

report

to

the

general

14

assembly

by

January

5,

2026,

with

the

departments’

findings,

15

proposed

eligibility

requirements,

and

any

short-term

and

16

long-term

costs

associated

with

coverage.

17

EXPLANATION

18

The

inclusion

of

this

explanation

does

not

constitute

agreement

with

19

the

explanation’s

substance

by

the

members

of

the

general

assembly.

20

This

bill

relates

to

the

department

of

health

and

human

21

services

(HHS)

and

the

department

of

administrative

services

22

(DAS)

review

of

anti-obesity

medication

for

purposes

of

the

23

medical

assistance

program

and

health

insurance

plans

for

state

24

employees

established

pursuant

to

Code

chapter

509A.

25

The

bill

requires

HHS

and

DAS

to

review

anti-obesity

26

medications,

including

GLP-1

agonists,

for

effectiveness,

27

comorbidities,

cost

savings,

eligibility

requirements,

and

28

short-term

and

long-term

costs

associated

with

coverage.

HHS

29

and

DAS

shall

submit

a

report

to

the

general

assembly

by

30

January

5,

2026,

containing

HHS’s

and

DAS’s

findings,

proposed

31

eligibility

requirements,

and

any

short-term

and

long-term

32

costs

associated

with

coverage.

33

-1-

LSB

1939SV

(2)

91

lh/ko

1/

1